News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Biomet Inc. Announces Fourth Quarter and Fiscal Year 2013 Final Financial Results
August 30, 2013
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Biomet, Inc. announced today final financial results for its fourth quarter and fiscal year ended May 31, 2013. This release replaces the Company’s earnings release dated July 11, 2013. The final results for the three and twelve months ended May 31, 2013 include the finalization of the goodwill impairment charge related to the Europe reporting unit and the correction of certain income tax accounts, which did not impact net sales.
Help employers find you! Check out all the
jobs
and
post your resume
.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Layoff Tracker
GSK Cuts 8 Employees in San Francisco
October 2, 2025
·
211 min read
·
BioSpace Editorial Staff
Cell therapy
Takeda Exits Cell Therapy Amid Strategic Pivot, Dealing Blow to Once Promising Modality
October 2, 2025
·
2 min read
·
Tristan Manalac
Cancer
AnaptysBio Plans Business Split To Sharpen Focus on Asset Value
October 1, 2025
·
2 min read
·
Tristan Manalac
Business
Novo Breaks $598M Heartseed Pact Amid ‘Decisive Restructuring’ by New CEO
October 1, 2025
·
2 min read
·
Tristan Manalac
